Phreesia Shares Outstanding 2019-2024 | PHR

Phreesia shares outstanding from 2019 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Phreesia Annual Shares Outstanding
(Millions of Shares)
2024 55
2023 52
2022 50
2021 40
2020 20
2019 2
2018 2
Phreesia Quarterly Shares Outstanding
(Millions of Shares)
2024-01-31 55
2023-10-31 55
2023-07-31 54
2023-04-30 53
2023-01-31 52
2022-10-31 53
2022-07-31 52
2022-04-30 52
2022-01-31 50
2021-10-31 51
2021-07-31 51
2021-04-30 45
2021-01-31 40
2020-10-31 39
2020-07-31 38
2020-04-30 37
2020-01-31 20
2019-10-31 36
2019-07-31 7
2019-04-30 2
2019-01-31
2018-10-31 2
2018-07-31 2
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.224B $0.356B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.555B 21.44
Inspire Medical Systems (INSP) United States $6.945B 0.00
IRhythm Technologies (IRTC) United States $3.488B 0.00
Axonics (AXNX) United States $3.415B 0.00
10x Genomics (TXG) United States $3.330B 0.00
Enovis (ENOV) United States $3.062B 23.26
Azenta (AZTA) United States $2.825B 230.23
Olink Holding AB (publ) (OLK) Sweden $2.719B 0.00
Hims & Hers Health (HIMS) United States $2.550B 0.00
Privia Health (PRVA) United States $2.145B 95.16
Schrodinger (SDGR) United States $1.756B 0.00
Omnicell (OMCL) United States $1.278B 31.27
Definitive Healthcare (DH) United States $0.832B 0.00
Standard BioTools (LAB) United States $0.731B 0.00
Fulgent Genetics (FLGT) United States $0.609B 0.00
Talkspace (TALK) United States $0.530B 0.00
Health Catalyst (HCAT) United States $0.327B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.324B 0.00
Clover Health Investments (CLOV) United States $0.315B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.160B 0.00
Butterfly Network (BFLY) United States $0.159B 0.00
American Well (AMWL) United States $0.158B 0.00
Augmedix (AUGX) United States $0.146B 0.00
MSP Recovery (LIFW) United States $0.133B 0.00
TruBridge (TBRG) United States $0.121B 5.17
Outset Medical (OM) United States $0.120B 0.00
111 (YI) China $0.085B 0.00
SHL Telemedicine (SHLT) Israel $0.076B 0.00
Future Health ESG (FHLT) United States $0.064B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00